These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16516981)

  • 41. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.
    Yuki N; Yamada M; Koga M; Odaka M; Susuki K; Tagawa Y; Ueda S; Kasama T; Ohnishi A; Hayashi S; Takahashi H; Kamijo M; Hirata K
    Ann Neurol; 2001 Jun; 49(6):712-20. PubMed ID: 11409422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T cell response in acute motor axonal neuropathy.
    Cencioni MT; Notturno F; Caporale CM; Creati B; Prencipe V; Battistini L; Uncini A
    Int J Immunopathol Pharmacol; 2009; 22(4):1043-50. PubMed ID: 20074468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome?
    Yuki N; Koga M; Hirata K
    Acta Neurol Scand; 2000 Aug; 102(2):132-4. PubMed ID: 10949532
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.
    Ang CW; Laman JD; Willison HJ; Wagner ER; Endtz HP; De Klerk MA; Tio-Gillen AP; Van den Braak N; Jacobs BC; Van Doorn PA
    Infect Immun; 2002 Mar; 70(3):1202-8. PubMed ID: 11854201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.
    Kuijf ML; Samsom JN; van Rijs W; Bax M; Huizinga R; Heikema AP; van Doorn PA; van Belkum A; van Kooyk Y; Burgers PC; Luider TM; Endtz HP; Nieuwenhuis EE; Jacobs BC
    J Immunol; 2010 Jul; 185(1):748-55. PubMed ID: 20525894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome.
    Jacobs BC; Hazenberg MP; van Doorn PA; Endtz HP; van der Meché FG
    J Infect Dis; 1997 Mar; 175(3):729-33. PubMed ID: 9041356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome.
    Jacobs BC; Endtz HP; van der Meché FG; Hazenberg MP; de Klerk MA; van Doorn PA
    J Neuroimmunol; 1997 Oct; 79(1):62-8. PubMed ID: 9357448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of a rabbit model of neuropathy induced by immunization with gangliosides.
    Moyano AL; Comín R; Lardone RD; Alaniz ME; Theaux R; Irazoqui FJ; Nores GA
    J Neurol Sci; 2008 Sep; 272(1-2):110-4. PubMed ID: 18573503
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subclass of IgG antibody to GM1 epitope-bearing lipopolysaccharide of Campylobacter jejuni in patients with Guillain-Barré syndrome.
    Yuki N; Ichihashi Y; Taki T
    J Neuroimmunol; 1995 Jul; 60(1-2):161-4. PubMed ID: 7543907
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome.
    Yuki N; Yamada M; Sato S; Ohama E; Kawase Y; Ikuta F; Miyatake T
    Muscle Nerve; 1993 Jun; 16(6):642-7. PubMed ID: 8502262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrophysiological studies in Guillain-Barré syndrome: correlation with antibodies to GM1, GD1B and Campylobacter jejuni.
    Vriesendorp FJ; Triggs WJ; Mayer RF; Koski CL
    J Neurol; 1995 Jul; 242(7):460-5. PubMed ID: 7595678
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Axonal Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni (PEN 43) enteritis].
    Ihara Y; Saito K; Yoshimoto S; Hayabara T; Yuki N
    Rinsho Shinkeigaku; 1995 Aug; 35(8):901-3. PubMed ID: 8665735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice.
    Sheikh KA; Zhang G; Gong Y; Schnaar RL; Griffin JW
    Ann Neurol; 2004 Aug; 56(2):228-39. PubMed ID: 15293275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Campylobacter jejuni DNA-binding protein from starved cells in Guillain-Barré syndrome patients.
    Kawamura N; Piao H; Minohara M; Matsushita T; Kusunoki S; Matsumoto H; Ikenaka K; Mizunoe Y; Kira J
    J Neuroimmunol; 2011 Dec; 240-241():74-8. PubMed ID: 21996079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seroreactivity to Campylobacter jejuni and gangliosides in patients with Guillain-Barré syndrome.
    von Wulffen H; Hartard C; Scharein E
    J Infect Dis; 1994 Oct; 170(4):828-33. PubMed ID: 7930724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High affinity of anti-GM1 antibodies is associated with disease onset in experimental neuropathy.
    Comín R; Yuki N; Lopez PH; Nores GA
    J Neurosci Res; 2006 Oct; 84(5):1085-90. PubMed ID: 16881049
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monospecific high-affinity and complement activating anti-GM1 antibodies are determinants in experimental axonal neuropathy.
    Notturno F; Del Boccio P; Luciani M; Caporale CM; Pieragostino D; Prencipe V; Sacchetta P; Uncini A
    J Neurol Sci; 2010 Jun; 293(1-2):76-81. PubMed ID: 20382399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis.
    Koga M; Yuki N; Hirata K
    J Neuroimmunol; 1999 May; 96(2):245-50. PubMed ID: 10337924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.